Respondents

Golden Claw Ventures, Inc. Q Therapeutics, Inc. Readaboo, Inc. Zika Diagnostics, Inc.

Administrative Proceeding File No. 3-18826 Table

Release Date
Release Number
Other Release Numbers
Name of Document
Release Date: Release Number:34-86813 Other Release Numbers: Name of Document: Opinion of the Commission
Release Date: Release Number:34-85329 Other Release Numbers: Name of Document: Order to Show Cause
Release Date: Release Number:34-84265 Other Release Numbers: Name of Document: Order Instituting Administrative Proceedings and Notice of Hearing Pursuant to Section 12(j) of the Securities Exchange Act of 1934